Your browser doesn't support javascript.
loading
Detection of Isoniazid-, Fluoroquinolone-, Amikacin-, and Kanamycin-Resistant Tuberculosis in an Automated, Multiplexed 10-Color Assay Suitable for Point-of-Care Use.
Chakravorty, Soumitesh; Roh, Sandy S; Glass, Jennifer; Smith, Laura E; Simmons, Ann Marie; Lund, Kevin; Lokhov, Sergey; Liu, Xin; Xu, Peng; Zhang, Guolong; Via, Laura E; Shen, Qingyu; Ruan, Xianglin; Yuan, Xing; Zhu, Hong Zhu; Viazovkina, Ekaterina; Shenai, Shubhada; Rowneki, Mazhgan; Lee, Jong Seok; Barry, Clifton E; Gao, Qian; Persing, David; Kwiatkawoski, Robert; Jones, Martin; Gall, Alexander; Alland, David.
Afiliação
  • Chakravorty S; Department of Medicine, New Jersey Medical School, Newark, New Jersey, USA chakraso@njms.rutgers.edu.
  • Roh SS; Department of Medicine, New Jersey Medical School, Newark, New Jersey, USA.
  • Glass J; Cepheid Inc., Sunnyvale, California, USA.
  • Smith LE; Department of Medicine, New Jersey Medical School, Newark, New Jersey, USA.
  • Simmons AM; Cepheid Inc., Sunnyvale, California, USA.
  • Lund K; Cepheid Inc., Bothell, Washington, USA.
  • Lokhov S; Cepheid Inc., Bothell, Washington, USA.
  • Liu X; Henan Provincial Chest Hospital, Zhengzhou, Henan Province, China.
  • Xu P; Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, Institutes of Biomedical Sciences and Institute of Medical Microbiology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
  • Zhang G; Sino-US International Research Center of Tuberculosis, Zhengzhou, China.
  • Via LE; Henan Public Health Clinical Center, Zhengzhou, China.
  • Shen Q; Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, NIAID, NIH, Bethesda, Maryland, USA.
  • Ruan X; Institute of Infectious Disease and Molecular Medicine, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Yuan X; Sino-US International Research Center of Tuberculosis, Zhengzhou, China.
  • Zhu HZ; Henan Provincial Chest Hospital, Zhengzhou, Henan Province, China.
  • Viazovkina E; Henan Provincial Chest Hospital, Zhengzhou, Henan Province, China.
  • Shenai S; Sino-US International Research Center of Tuberculosis, Zhengzhou, China.
  • Rowneki M; Cepheid Inc., Bothell, Washington, USA.
  • Lee JS; Department of Medicine, New Jersey Medical School, Newark, New Jersey, USA.
  • Barry CE; Department of Medicine, New Jersey Medical School, Newark, New Jersey, USA.
  • Gao Q; Department of Microbiology, International Tuberculosis Research Center, Changwon, Gyeongsnag, Republic of Korea.
  • Persing D; Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, NIAID, NIH, Bethesda, Maryland, USA.
  • Kwiatkawoski R; Institute of Infectious Disease and Molecular Medicine, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Jones M; Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, Institutes of Biomedical Sciences and Institute of Medical Microbiology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
  • Gall A; Cepheid Inc., Sunnyvale, California, USA.
  • Alland D; Cepheid Inc., Sunnyvale, California, USA.
J Clin Microbiol ; 55(1): 183-198, 2017 01.
Article em En | MEDLINE | ID: mdl-27807153
ABSTRACT
Extensively drug-resistant (XDR) tuberculosis (TB) cannot be easily or quickly diagnosed. We developed a rapid, automated assay for the detection of XDR-TB plus resistance to the drug isoniazid (INH) for point-of-care use. Using a simple filter-based cartridge with an integrated sample processing function, the assay identified a wide selection of wild-type and mutant sequences associated with XDR-TB directly from sputum. Four new large-Stokes-shift fluorophores were developed. When these four Stokes-shift fluorophores were combined with six conventional fluorophores, 10-color probe detection in a single PCR tube was enabled. A new three-phase, double-nested PCR approach allowed robust melting temperature analysis with enhanced limits of detection (LODs). Finally, newly designed sloppy molecular beacons identified many different mutations using a small number of probes. The assay correctly distinguished wild-type sequences from 32 commonly occurring mutant sequences tested in gyrA, gyrB, katG, and rrs genes and the promoters of inhA and eis genes responsible for resistance to INH, the fluoroquinolone (FQ) drugs, amikacin (AMK), and kanamycin (KAN). The LOD was 300 CFU of Mycobacterium tuberculosis in 1 ml sputum. The rate of detection of heteroresistance by the assay was equivalent to that by Sanger sequencing. In a blind study of 24 clinical sputum samples, resistance mutations were detected in all targets with 100% sensitivity, with the specificity being 93.7 to 100%. Compared to the results of phenotypic susceptibility testing, the sensitivity of the assay was 75% for FQs and 100% each for INH, AMK, and KAN and the specificity was 100% for INH and FQ and 94% for AMK and KAN. Our approach could enable testing for XDR-TB in point-of-care settings, potentially identifying highly drug-resistant TB more quickly and simply than currently available methods.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Sistemas Automatizados de Assistência Junto ao Leito / Técnicas de Diagnóstico Molecular / Tuberculose Extensivamente Resistente a Medicamentos / Mycobacterium tuberculosis / Antituberculosos Tipo de estudo: Clinical_trials / Diagnostic_studies / Evaluation_studies / Prognostic_studies Limite: Humans Idioma: En Revista: J Clin Microbiol Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Sistemas Automatizados de Assistência Junto ao Leito / Técnicas de Diagnóstico Molecular / Tuberculose Extensivamente Resistente a Medicamentos / Mycobacterium tuberculosis / Antituberculosos Tipo de estudo: Clinical_trials / Diagnostic_studies / Evaluation_studies / Prognostic_studies Limite: Humans Idioma: En Revista: J Clin Microbiol Ano de publicação: 2017 Tipo de documento: Article